Other Sites
- tummy tuck cost
- tummy tuck surgery
- breast enhancement
- saline breast implants
- Affordable medical tourism
- Boob job cost
- lower blepharoplasty
- What is medical tourism
- medical tourism companies
- breast augmentation surgery
- Calf implants
- Breast lift and augmentation
- abdominoplasty surgery cost
- breast enlargement surgery
- How much do breast implants cost
- body contouring surgery
- breast implant cost
- celebrity plastic surgery
- how much are breast implants
- The Truth about Silicone Breast Implants
-
Category Archives: Cell Therapy
Pluristem stem cell therapy saves a patient, shares jump
Wed May 9, 2012 3:35pm BST (Reuters) – Pluristem Therapeutics Inc said a 7-year old girl suffering from a bone marrow disease experienced a reversal of her condition after receiving its experimental stem cell therapy, sending the Israeli company’s shares up 32 percent. Continue reading
Posted in Cell Therapy
Tagged a-7-year-old, acute-radiation, after-receiving, commonly-called, intermittent, mid-stage-trial, pluristem, studies-showed
Comments Off
Generational Achievements in Gene and Cell Therapy Honored at ASGCT 15th Annual Meeting
The American Society of Gene & Cell Therapy is pleased to honor Dr. David Williams, MD, as the recipient of the Outstanding Achievement Award at the Society’s 15th Annual Meeting on Saturday, May 19th.Milwaukee, WI (PRWEB) May 04, 2012 Pioneering researcher recognized for scientific achievements in gene and cell therapyThe American Society of Gene & Cell Therapy is pleased to honor Dr. David … Continue reading
Posted in Cell Therapy
Tagged annual-meeting, award, david-williams, for-scientific, gene-and, outstanding, prweb, recipient, researcher-recognized, saturday, williams
Comments Off
Stem Cell Therapy for Stroke – Video
30-04-2012 10:22 Millions of stem cells derived from the bone marrow of healthy adult donors have been implanted in the brains of two stroke survivors at UPMC, as part of a two-site trial to determine whether bone marrow stem cells injected into the brain have therapeutic value in the healing of stroke lesions. The researchers are seeking participants between the ages of 18 and 75 who have had an ischemic stroke between six months and three years before study entry. For more information, visit: Continue reading
Posted in Cell Therapy
Tagged are-seeking, between-the, brain, from-the-bone, healing, healthy-adult, injected-into, two-site-trial
Comments Off
Juvenile Parkinson’s – Stem cell therapy – Video
01-05-2012 12:12 This video, is a testimonial of a patient from Uruguay that went to Progencell, to get treatment Juvenile Parkinson’s . Talks about his experience, the procedure, the outcome and some suggestions. Language spanish with English subtitles, 7:10 min duration aprox. Continue reading
Posted in Cell Therapy
Tagged and-some, english, experience, get-treatment, juvenile, juvenile-parkinson, min-duration, outcome, patient-from, procedure, the-outcome, the-procedure, uruguay, video
Comments Off
Nuvilex, Inc. Retains Dawson James Financial Services and Moves to Finalize SG Austria Asset Acquisition
SILVER SPRING, Md.–(BUSINESS WIRE)– Nuvilex, Inc. Continue reading
Posted in Cell Therapy
Tagged a-key-step, a-over-the, business-goals-, corporate, near-completion, press, treatment-which, treatments
Comments Off
Opexa to Hold Preliminary Investigator’s Meeting for MS Trial at American Academy of Neurology Annual Meeting
THE WOODLANDS, Texas–(BUSINESS WIRE)– Opexa Therapeutics, Inc. (NASDAQ: OPXA – News), a biotechnology company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company will be holding a preliminary meeting with prospective clinical trial investigators at the 64th Annual American Academy of Neurology (AAN) Meeting in New Orleans on April 24, 2012. The purpose of this meeting will be to discuss the upcoming Phase IIb clinical trial using Opexas T-cell therapy in patients with Secondary Progressive Multiple Sclerosis (SPMS). Continue reading
Posted in Cell Therapy
Tagged ability, clinical, dependence-, development, meeting-, multiple, neurology, opexas-t-cell, president, press-release-, securities, tovaxin, treatment, united-states
Comments Off
NeoStem Announces Pricing of Public Offering for $6,000,000 in Gross Proceeds
NEW YORK, March 29, 2012 (GLOBE NEWSWIRE) — NeoStem, Inc. (NYSE Amex:NBS) (“NeoStem” or “the Company”), a leader in the cell therapy industry, announced today the pricing of an underwritten public offering of 15,000,000 units at $0.40 per unit Continue reading
Posted in Cell Therapy
Tagged a-cell-therapy, a-heart-attack, Cell Therapy, current-report, exchange, exchange-commission, information, maxim-group, progenitor, report-on-form, technology, underwriters
Comments Off
NeoStem Announces Proposed Public Offering of Common Stock and Warrants
NEW YORK, March 28, 2012 (GLOBE NEWSWIRE) — NeoStem, Inc. (NYSE Amex:NBS) (“NeoStem” or “the Company”), a leader in the cell therapy industry, today announced that it intends to offer and sell shares of its common stock and warrants in an underwritten public offering. All of the shares and warrants in the offering will be sold by NeoStem. Continue reading
Posted in Cell Therapy
Tagged a-cell-therapy, a-premier-cell, cell-, jurisdiction, manufacturing, maxim-group, offering, press-release-, progenitor, website-at-http, with-the, with-the-sec, york
Comments Off
Stem cell therapy for the repair of myocardium in heart failure patients – Video
28-03-2012 10:17 Dr Joshua Hare is Professor of Medicine and Director of the Interdisciplinary Stem Cell Institute at the University of Miami. The interview was conducted on 25 March 2012 at the American College of Cardiology’s (ACC’s) 61st Annual Scientific Session & Expo in Chicago. See more ACC.12 Coverage: www.getinsidehealth.com Continue reading
Posted in Cell Therapy
Tagged acc, annual, chicago, joshua, joshua-hare, march, medicine, professor, university
Comments Off